Discover 1,443 paid clinical trials in Tampa, Florida. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,443
The Rhythm Evaluation for AntiCoagulaTion With Continuous Monitoring of Atrial Fibrillation
Cleaner Long-tErm Assessment Registry - Venous Insights and Efficacy With eXtended Tracking
for
Deep Vein Thrombosis (DVT),
Location: Tampa FL, Fort Lauderdale FL, Edgewood KY, Plano TX
Sponsor: Argon Medical Devices
Sex: All
Age: 18+
Code: NCT07102160
Recruiting
Phase III Study Investigating Heart Failure and Cardiovascular Death With Baxdrostat in Combination With Dapagliflozin
for
Heart Failure
Location: Lakeland FL, Crystal River FL, Orlando FL,
Sponsor: AstraZeneca
Sex: All
Age: 40+
Code: NCT06677060
Phase3, Recruiting
A Study to Compare the Efficacy and Safety of BMS-986489 (Atigotatug+ Nivolumab Fixed Dose Combination) in Combination With Carboplatin Plus Etoposide to That of Atezolizumab With Carboplatin Plus Etoposide as First-Line Therapy in Participants With Extensive-Stage Small Cell Lung Cancer (TIGOS).
for
Extensive-Stage Small Cell Lung Cancer
Location: St. Petersburg FL, Orange City FL, Fort Myers FL,
Sponsor: Bristol-Myers Squibb
Sex: All
Age: 18+
Code: NCT06646276
Phase3, Recruiting
Product Surveillance Registry
for
Cardiac Rhythm Disorders, Urological Disorders,
Location: Tampa FL, Safety Harbor FL, Clearwater FL, Bradenton FL,
Sponsor: Medtronic
Sex: All
Age: 0+
Code: NCT01524276
Recruiting
DEFIANCE: RCT of ClotTriever System Versus Anticoagulation In Deep Vein Thrombosis
for
Venous Thromboembolism, Deep Venous Thrombosis,
Location: Tampa FL, Sarasota FL, Spartanburg SC, Nashville TN,
Sponsor: Inari Medical
Sex: All
Age: 18+
Code: NCT05701917
Recruiting
Study of Olatorepatide in Adult Participants Living With Overweight or Obesity Without Diabetes
for
Overweight or Obesity
Location: St. Petersburg FL, Inverness FL, The Villages FL,
Sponsor: Regeneron Pharmaceuticals
Sex: All
Age: 18+
Code: NCT07685808
Phase2, Recruiting
A Phase 1/2a Study of DB-1303/BNT323 in Advanced/Metastatic Solid Tumors